Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies.
J Mol Diagn
; 26(1): 5-16, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37981089
Full text:
1
Database:
MEDLINE
Main subject:
Myeloproliferative Disorders
/
Neoplasms
Limits:
Humans
Language:
En
Year:
2024
Type:
Article